1-3 of 3
Naru Sato
Close
Sort by
Journal Articles

Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor Treatment

Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, Shuhei Asada, Keita Yamamoto, Naru Sato, Yutaka Enomoto, Yosuke Tanaka, Keiko Katoh, Kaori Saitoh, Takamasa Ishikawa, Hitoshi Sato, Tomoyoshi Soga, Yasuhito Nannya, Makoto Nakanishi, Daiju Kitagawa, Toshio Kitamura, Susumu Goyama
Journal: Blood
Blood (2022) 140 (Supplement 1): 8776–8777.
https://doi.org/10.1182/blood-2022-168499
Published: 2022
Journal Articles

Mutant ASXL1 Promotes Expansion of the Phenotypic Hematopoietic Stem Cell Compartment

Takeshi Fujino, MD, Susumu Goyama, MD PhD, Yuki Sugiura, PhD, Daichi Inoue, MD PhD, Satoshi Yamasaki, PhD, Akiko Matsumoto, Naru Sato, MD, Hironobu Morinaga, PhD, Shiori Shikata, Tomofusa Fukuyama, MD PhD, Yosuke Tanaka, PhD, Shuhei Asada, MD PhD, Tsuyoshi Fukushima, MD PhD, Hiroaki Honda, MD PhD, Emi K Nishimura, MD PhD, Tatsuhiro Shibata, MD PhD, Makoto Suematsu, MD PhD, Toshio Kitamura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 821.
https://doi.org/10.1182/blood-2019-127904
Published: 2019
Journal Articles

The Efficacy of Time-Sequential Administration of GO After Conventional Chemotherapy for AML

Satoru Takada, M.D., Naru Sato, M.D., Nobuhiko Kobayashi, M.D., Hoshino Takumi, M.D., Nahoko Hatsumi, M.D., Toru Sakura, M.D.
Journal: Blood
Blood (2012) 120 (21): 4338.
https://doi.org/10.1182/blood.V120.21.4338.4338
Published: 2012